ZyVersa Therapeutics, Inc.
ZVSA· OTC
ZVSAZyVersa Therapeutics, Inc.
Filed May 12, 2023 · 10-Q · 42 days after period end · 0001493152-23-016480
| Metric | Q1 2023 | Q1 2022 |
|---|---|---|
| Net Income | -$3.54M | -$720.01K |
| EPS Diluted | -$135.88 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ZyVersa Therapeutics, Inc. · CIK 1859007 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 12, 2023 · 42 d after period end
